Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Developing consensus-based priority outcome domains for trials in kidney transplantation: a multinational Delphi Survey with patients, caregivers, and health professionals|
|Citation:||Transplantation, 2017; 101(8):1875-1886|
|Publisher:||Lippincott Williams & Wilkins|
|Bénédicte Sautenet ... Shilpa Jesudason ... Stephen P. McDonald ... et al.|
|Abstract:||Background. Inconsistencies in outcome reporting and frequent omission of patient-centered outcomes can diminish the value of trials in treatment decision making. We identified critically important outcome domains in kidney transplantation based on the shared priorities of patients/caregivers and health professionals. Methods. In a 3-round Delphi survey, patients/caregivers and health professionals rated the importance of outcome domains for trials in kidney transplantation on a 9-point Likert scale and provided comments.During rounds 2 and 3, participants rerated the outcomes after reviewing their own score, the distribution of the respondents' scores, and comments. We calculated the median, mean, and proportion rating 7 to 9 (critically important), and analyzed comments thematically. Results. One thousand eighteen participants (461 [45%] patients/caregivers and 557 [55%] health professionals) from 79 countries completed round 1, and 779 (77%) completed round 3. The top 8 outcomes that met the consensus criteria in round 3 (mean, ≥7.5; median, ≥8; proportion, >85%) in both groups were graft loss, graft function, chronic rejection, acute rejection, mortality, infection, cancer (excluding skin), and cardiovascular disease. Compared with health professionals, patients/caregivers gave higher priority to 6 outcomes (mean difference of 0.5 or more): skin cancer, surgical complications, cognition, blood pressure, depression, and ability to work. We identified 5 themes: capacity to control and inevitability, personal relevance, debilitating repercussions, gaining awareness of risks, and addressing knowledge gaps. Conclusions. Graft complications and severe comorbidities were critically important for both stakeholder groups. These stakeholderprioritized outcomes will inform the core outcome set to improve the consistency and relevance of trials in kidney transplantation.|
Clinical Trials as Topic
Surveys and Questionnaires
Outcome Assessment, Health Care
|Rights:||Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.|
|Appears in Collections:||Aurora harvest 3|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.